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ABSTRACT
Dual-specificity tyrosine (Y)-phosphorylation-regulated protein kinase 1A (Dyrk1A) is 
the mammalian homologue of Drosophila melanogaster minibrain and its human gene 
is mapped to the Down syndrome critical region of chromosome 21. Dyrk1A 
phosphorylates several transcription factors, including NFAT and CREB and a number 
of cytosolic proteins such as APP, tau, and α-synuclein. Although Dyrk1A is involved 
in the control of cell growth and postembryonic neurogenesis, its potential role during 
cell death and signaling pathway is not clearly understood. In the present study, we 
show that Dyrk1A is activated under the condition of apoptotic cell death. In addition, 
Dyrk1A is coupled to JNK1 activation, and directly interacts with apoptosis signal- 
regulating kinase 1 (ASK1). Moreover, Dyrk1A positively regulates ASK1-mediated 
JNK1-signaling, and appears to directly phosphorylate ASK1. These data indicate that 
Dyrk1A regulates cell death through facilitating ASK1-mediated signaling events.
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INTRODUCTION
Dual-specificity tyrosine (Y)-phosphorylation-regulated 
protein  kinase  1A  (Dyrk1A)  is  firstly  identified  as 
Minibrain in Drosophila (Tejedor et al., 1995). Dyrk1A 
is  mapped  within  the  Down  syndrome  (DS)  critical 
region  (a  4-megabase  region  containing  60∼100 
genes  between  markers  D21S17  and  ETS2)  of 
chromosome  21,  which  is  associated  with  a  variety 
of  DS  abnormalities,  including  mental  retardation 
(Smith et al., 1997). Transgenic mice carrying extra 
copies of Dyrk1A exhibit neurodevelopmental delays, 
motor abnormalities, and cognitive deficits (Altafaj et 
al.,  2001).  Dyrk1A  knockout  mice  also  show  a 
general  delay  in  fetal  development  and  embryonic 
lethality,  indicating  the  vital  and  non-redundant 
biological  functions  of  Dyrk1A  (Fotaki  et  al.,  2002).
    Diverse types of proteins have been identified as 
the  substrates  of  Dyrk1A,  including  transcription 
factors,  including  NF-AT  and  Forkhead  (Woods  et 
al.,  2001;  Arron  et  al.,  2006;  Gwack  et  al.,  2006), 
several  endocytosis  and  synaptic  vesicle  recycling 
proteins,  such  as  dynamin  1  and  amphiphysin  1 
(Chen-Hwang  et  al.,  2002;  Murakami  et  al.,  2006), 
and cytosolic proteins, such as APP and tau (Ryoo 
et al., 2007; Ryoo et al., 2008), implying that Dyrk1A 
participates  in  various  biological  responses.  Regar-
ding to the functional role of Dyrk1A, active Dyrk1A 
phosphorylates  the  transcription  factor  cAMP  res-
ponse element (CRE)-binding protein (CREB), which 
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mediated gene transcription during neuronal differen-
tiation (Yang et al., 2001). Yak1p, the Saccharomyces 
cerevisiae  homolog  of  Dyrk1A,  was  identified  as  a 
functional  antagonist  of  the  RAS/protein  kinase  A 
pathway and has been characterized as a negative 
regulator of growth (Holtzman et al., 1993; Raths et 
al.,  1993).  Thus,  it  is  suggested  that  Dyrk1A  is  a 
key  regulator  of  neuronal  cell  growth  and  differen-
tiation.
    Recently,  Dyrk1A  appears  to  be  involved  in  the 
pathogenesis of several neurodegenerative diseases 
such  as  Alzheimer’s  disease  (AD),  Parkinson’s 
disease, and  Huntington’s disease  (HD). For  exam-
ple,  Dyrk1A  phosphorylates  α-synuclein  and  regul-
ates its inclusion formation, and potentially affecting 
neuronal cell viability (Kim et al., 2006). In addition, 
up-regulation  of  Dyrk1A  in  immortalized  hippocampal 
progenitor H19-7 cells causes AD-like pathogenesis 
through  the  formation  of  tau  inclusion  and  the 
generation  of  β-amyloid  fragment  (Park  et  al., 
2007).  However,  the  exact  role  of  Dyrk1A  and  its 
signal  transduction  leading  to  cell  death  is  not 
clearly  elucidated  yet.
Apoptosis  signal-regulating  kinase  1  (ASK1),  a 
member  of  the  mitogen-activated  protein  kinase 
kinase  kinase  family,  is  composed  of  an  inhibitory 
N-terminal  domain,  a  kinase  domain,  and  a  C- 
terminal regulatory domain (Ichijo et al., 1997). ASK1 
can  promote  apoptosis  in  response  to  common 
pro-apoptotic  stresses,  such  as  oxidative  stress 
(Song et al., 2002), death receptor ligands (Nishitoh 
et  al.,  1998),  and  endoplasmic  reticulum  stress 
(Nishitoh  et  al.,  2002).  ASK1  also  phosphorylates 
and activates both p38 and JNK pathways (Ichijo et 
al.,  1997).  The  mechanism  of  ASK1  activation  is 
positively  regulated  by  its  binding  proteins  such  as 
TNF  receptor-ssociated  factors  2/6  (Noguchi  et  al., 
2005) and Daxx (Chang et al., 1998). On the other 
hand, several cellular proteins, including thioredoxin 
(Saitoh  et  al.,  1998),  Hsp90  (Zhang  et  al.,  2005), 
and 14-3-3 (Zhang et al., 1999), have been reported 
to  interact  with  ASK1  and  inhibit  ASK1  activity.
In the present study, we investigated whether and 
how  Dyrk1A  becomes  activated  during  cell  death. 
We  found  that  Dyrk1A  is  linked  to  JNK  signaling 
pathway  and  acts  as  the  upstream  kinase  of  JNK. 
Additionally,  Dyrk1A  interacts  with  and  positively 
regulates ASK1 under various cell death conditions. 
These  finding  suggest  that  Dyrk1A  plays  an 
important  role  in  ASK1-mediated  transmission  of 
cell  death  signals.
MATERIALS  AND  METHODS
Materials
Dulbecco’s  modified  Eagle’s  medium  (DMEM), 
fetal  bovine  serum  (FBS),  LipofectAMINE  PLUS 
reagent, anti-Xpress, horseradish peroxidase-conjugated 
anti-rabbit,  and  anti-mouse  IgGs  were  purchased 
from  Invitrogen  (Carlsbad,  CA,  USA).  Enhanced 
chemiluminescence (ECL) reagents and [γ-
32P]ATP 
were  purchased  from  Perkin-Elmer  Life  and 
Analytical  Sciences  (Waltham,  MA,  USA).  Gluta-
thione-Sepharose  4B  and  Protein  A-Sepharose 
were  obtained  from  Amersham  Biosciences  (Pisca-
taway,  NJ,  USA).  Anti-phosphoASK1  (Thr-845),  anti- 
phosphoJNK,  and  anti-Dyrk1A  antibodies  were  pur-
chased  from  Cell  Signaling  Technology  (Beverly, 
MA, USA). Anti-HA, anti-ASK1, anti-JNK, anti-Hsp90, 
mouse  immunoglobulins  (IgGs)  were  purchased 
from  Santa  Cruz  Biotechnology  (Santa  Cruz,  CA, 
USA).  Anti-Dyrk1A  antibody  was  purchased  from 
Abnova  Corporation  (Taipei  City,  Taiwan).  Anti- 
phosphotyrosine  antibody  was  purchased  from 
Upstate  Biotechnology  (Lake  Placid,  NY,  USA). 
Anti-Flag  antibodies  and  all  other  chemicals  were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Mammalian constructs encoding wild-type and kinase- 
inactive  rat  Dyrk1A  tagged  with  hemagglutinin  (HA) 
(pSVL-HA-Dyrk1A WT and K188R) were a kind gift 
from  W.  Becker  (Institut  fur  Pharmakologie  und 
Toxikologie,  Universitatsklinikum  der  RWTH,  Ger-
many). Plasmids encoding 6xHis-Xpress-tagged wild- 
type  and  K188R  mutant  Dyrk1A  (pcDNA4/HisMax- 
Dyrk1A  WT  and  K188R)  were  generated  as 
described  previously  (Park  et  al.,  2007).  Constructs 
encoding  HA-tagged  forms  of  ASK1,  ASK1ΔN, 
ASK1ΔC,  ASK1-NT,  and  Flag-ASK1  was  kindly 
provided  by  E.J.  Choi  (Korea  University,  Seoul, 
Korea).
Cell  culture  and  preparation  of  cell  lysates
    Human  embryonic  kidney  293  (HEK293)  cells 
were maintained in DMEM containing 10% FBS and 
100  unit/ml  penicillin-streptomycin.  The  cells  were 
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LipofectAMINE  PLUS  reagent,  according  to  the 
manufacturer’s  protocols.  In  order  to  prepare  cell 
lysates,  the  cells  were  rinsed  twice  with  ice-cold 
phosphate-buffered  saline,  and  then  solubilized  in 
lysis  buffer  (50  mM  Tris,  pH  7.5,  containing  1.0% 
Nonidet  P-40,  150  mM  NaCl,  10%  glycerol,  1  mM 
Na3VO4, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 1 mM 
EGTA, 1 mM EDTA,10 mM NaF, and 0.2 mM phenyl-
methylsulfonyl  fluoride).  The  cells  were  scraped, 
and  the  supernatants  were  collected  after  centri-
fugation  for  20  min  at  14,000xg  at  4
oC.
Immunoprecipitation  and  immunoblot  assay
    One  microgram  of  suitable  antibodies  was  incu-
bated  with  0.5  to  1  mg  of  cell  extracts  prepared  in 
cell lysis buffer overnight at 4
oC. Fifty microliter of a 
1：1  suspension  of  Protein  A-Sepharose  beads 
was added and incubated for 2 h at 4
oC with gentle 
rotation.  After  beads  were  pelleted  and  washed 
extensively with cell lysis buffer, the immunocomplexes 
were  dissociated  by  boiling  in  SDS-PAGE  sample 
buffer, separated onto SDS-PAGE gel, and transferred 
to  a  nitrocellulose  membrane  (Millipore,  Japan). 
Membranes  were  then  blocked  in  TBST  buffer  (20 
mM  Tris,  pH  7.5,  137  mM  NaCl,  and  0.1%  Tween 
20)  plus  5%  nonfat  dry  milk  for  1  h  at  room  tem-
perature,  and  incubated  overnight  at  4
oC  in  TBST 
buffer  with  3%  nonfat  dry  milk  and  the  appropriate 
primary  antibodies.  Membranes  were  washed  three 
times in TBST, and then incubated with appropriate 
secondary IgG-coupled horseradish peroxidase anti-
bodies for 1 h at room temperature. The membranes 
were washed three times with TBST and visualized 
with  ECL  reagent.
In  vitro  kinase  assay
    After  cells  were  harvested  and  lysed  in  lysis 
buffer,  the  protein  extracts  (∼500  μg)  were  incu-
bated  with  appropriate  antibody  for  overnight  at 
4
oC. The immunocomplexes were mixed with protein 
A-Sepharose  beads,  and  washed  three  times  in 
lysis buffer. For JNK assay, the kinase reaction was 
carried  out  at  30
oC  for  30  min  in  20  μl  of  kinase 
buffer  (25  mM  HEPES,  pH  7.4,  25  mM  glycero-
phosphate,  25  mM  MgCl2,  100  μM  sodium  ortho-
vanadate)  containing  10  μM  ATP,  5  μCi  of  [γ- 
32P] ATP, and 5 μg GST-c-Jun as a substrate. For 
Dyrk1A  kinase  assay,  immunocomplexes  were 
resuspended  in  the  kinase  reaction  buffer  (20  mM 
Tris-HCl, pH 7.5, 20 mM MgCl2) containing 10 μM 
ATP, 5 μCi [γ-
32P]ATP, and incubated for 15 min 
at 30
oC  in  the  presence  of  5 μg  of  GST-ASK1  as 
a  substrate.  The  reactions  were  stopped  by  adding 
SDS-sample  buffer,  and  analyzed  by  SDS-PAGE 
followed  by  autoradiography.
RESULTS
Dyrk1A  becomes  activated  by  toxic  stimuli, 
such  as  TNFα and  hydrogen  peroxide
    In  a  previous  report  we  have  shown  that  the 
addition  of  etoposide  to  embryonic  hippocampal 
H19-7  cells  causes  the  activation  of  Dyrk1A,  which 
facilitates  the  interaction  between  Hip-1  and  cas-
pase-3  and  then  leads  to  the  cell  death  (Kang  et 
al.,  2005).  In  addition  to  etoposide,  we  firstly  exa-
mined whether Dyrk1A becomes activated upon the 
stimulation  with  other  toxic  stimuli,  such  as  tumor 
necrosis  factor-α (TNFα)  and  hydrogen  peroxide 
(H2O2).  After  HEK293  cells  were  incubated  with 
hydrogen  peroxide  or  TNFα,  cell  lysates  were 
subjected  to  immunoprecipitation  with  anti-Dyrk1A, 
followed by immunoblotting with anti-phosphotyrosine. 
As  shown  in  Fig.  1,  the  auto-phosphorylation  of 
Dyrk1A  was  significantly  increased  upon  the  expo-
sure  to  these  two  stimuli,  reaching  the  maximum 
value  of  Dyrk1A  activity  at  2  hr  and  sustained 
thereafter  until  4  hr  of  post-stimuli  treatment.  The 
quantification  of  the  phospho-Dyrk1A  bands 
revealed a 14.92- and 1.81-fold increase of Dyrk1A 
activity in response to TNFα and H2O2,  respectively 
(Fig.  1).  These  results  suggest  that  Dyrk1A  becomes 
activated  in  response  to  toxic  stimuli.
Dyrk1A  stimulates  JNK  activity
    Based  on  the  finding  that  intracellular  JNK 
signaling  pathway  is  activated  by  exposure  with 
pro-inflammatory  cytokines  and  cellular  stress 
stimuli, such  as etoposide  and H2O2 (Ip and  Davis, 
1998),  we  next  examined  whether  Dyrk1A  is  linked 
to JNK signaling pathway, and if it occurs, how they 
interact  together  in  a  biochemical  and  functional 
mode. After HEK293 cells were mock-transfected or 
transfected  with  Xpress-Dyrk1A  for  24  hr  followed 
by  treatment  with  etoposide,  cell  lysates  were 
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Fig.  1.  Effect  of  TNFα and  hydrogen  peroxide  on  Dyrk1A  acti-
vation. Where indicated, HEK293 cells were incubated with either 
TNFα (100 ng/ml; A) or H2O2 (1 mM; B) for the indicated times. 
Cell  lysates  were  subjected  to  immunoprecipitation  with  anti- 
Dyrk1A,  and  the  levels  of  Dyrk1A  and  active  Dyrk1A  were 
analyzed  by  immunoblot  using  anti-Dyrk1A  or  anti-phosphotyro-
sine  IgGs.
Fig. 2. Dyrk1A potentiates JNK activation. (A) HEK293 cells were 
either  mock-transfected  or  transfected  with  Xpress-Dyrk1A  in  a 
dose-dependent  manner  for  24  hr,  as  indicated.  Then  the  cells 
were stimulated with etoposide (50 μM) for 1 hr, and cell lysates 
were subjected to immunoblot with anti-Xpress, anti-phosphoJNK, 
and  anti-JNK  IgGs.  (B)  Where  indicated,  HEK293  cells  were 
transfected for 24 h with a plasmid encoding Xpress-tagged wild 
type  Dyrk1A  (Xpress-Dyrk1A-WT)  or  kinase-defective  K188R 
mutant  (Xpress-Dyrk1A-KD),  or  HA-tagged  kinase-inactive  SEK 
mutant. Then, the cells were preincubated with SP600125 (20 μM) 
for  24  hr,  and  treated  with  etoposide  (50  μM )  f o r  1  h r ,  a s  
indicated.  After  cells  were  immunoprecipitated  with  anti-JNK 
antibodies,  the  JNK  activity  of  immunocomplexes  was  examined 
by  in  vitro  kinase  assay  using  GST-c-Jun  as  a  substrate.  To 
check  the  proper  expression  of  plasmid,  cell  lysates  were 
immunoblotted  with  anti-Xpress  or  anti-HA  antibodies.
Fig. 2A, while the addition of etoposide caused JNK 
activation, transfection of  wild type  Dyrk1A  led to a 
synergistic  increase  in  the  level  of  phospho-JNK  in 
a dose-dependent manner. To further check whether 
Dyrk1A  causes  the  JNK  activation,  in  vitro  kinase 
assay was performed. HEK293 cells were transfected 
a  plasmid  encoding  either  Xpress-tagged  wild  type 
Dyrk1A (Xpress-Dyrk1A) or its kinase-deficient mutant 
(Xpress-Dyrk1A-K188R), or HA-tagged kinase-defective 
SEK1,  the  upstream  activator  of  JNK  (HA-SEK 
mutant),  and/or  pre-incubated  with  JNK  inhibitor 
SP600125  for  24  hr.  The  cells  were  then  left  un- 
stimulated  or  treated  with  etoposide  for  1  hr,  and 
the  total  cell  lysates  were  immunoprecipitated  with 
anti-JNK followed by in vitro kinase assay by using 
bacterial  recombinant  c-Jun  fused  to  GST  as  a 
substrate. As shown in Fig. 2B, the phosphorylation 
of  GST-c-Jun  was  enhanced  upon  the  stimulation 
with  etoposide.  Furthermore,  the  expression  of 
Dyrk1A resulted in an enhancement of phosphorylated 
c-Jun  levels,  compared  with  the  cells  stimulated  by 
etoposide  alone  (Fig.  2B).  Meanwhile,  marked  re-
duction of phospho-c-Jun levels was observed under 
the inhibition of Dyrk1A arising from the transfection 
of  kinase-deficient  Dyrk1A  mutant.  These  results 
suggest  that  Dyrk1A  activates  JNK  signaling  path-
way.  This  finding  was  further  supported  by  the 
observation  that  the  levels  of  phospho-c-Jun  were 
decreased  by  JNK  inhibitor  (SP600125)  or  kinase- 
deficient  SEK  mutant  type  (Fig.  2B),  which  is  pre-
sent  upstream  component  of  apoptotic  JNK  path-
way.
Dyrk1A binds to ASK1, which is enhanced by 
toxic  stimuli
    To  further  characterize  how  Dyrk1A  is  linked  to 
JNK  pathway,  we  examined  the  possibility  that 
Dyrk1A  directly  interacts  with  JNK.  After  HEK293 Functional  Link  between  Dyrk1A  and  ASK1 39
Fig.  3.  Dyrk1A  does  not  interact  with  ASK1.  After  HEK293  cells 
were  transfected  for  24  hr  with  Xpress-Dyrk1A  or/and  Flag-JNK, 
cell lysates were subjected to immunoprecipitation with anti-Flag, 
followed  by  immunoblot  with  anti-Xpress  or  anti-Flag  IgGs.  As  a 
control,  cell  lysates  were  also  immunoblotted  with  anti-Xpress 
and  anti-Flag  antiserum.
Fig.  4.  Dyrk1A  binds  to  ASK1.  (A)  HEK293  cells  were  transfected  for  24  h  with  Xpress-Dyrk1A  or/and  HA-ASK1.  Cell  lysates  were 
subjected  to  immunoprecipitation  with  anti-HA,  and  then  immunoblot  assay  was  performed  with  anti-Xpress  or  anti-HA  antibodies. T o  
examine  the  proper  expression  of  plasmid,  cell  lysates  were  immunoblotted  with  anti-HA  and  anti-Xpress  IgGs.  (B)  After  HEK293  cells 
w e r e  t r a n s f e c t e d  f o r  2 4  h  w i t h  F l a g - A S K 1  a l o n e  o r  t o g e t h e r  w i t h   either  Xpress-tagged  wild  type  (WT)  or  kinase-defective  Dyrk1A ( K D ) ,  
cell  lysates  were  subjected  to  immunoprecipitation  with  anti-Flag,  followed  by  immunoblot  assay  with  anti-Xpress  antibodies.  The  proper 
expression  of  plasmid  was  examined  by  immunoblot  assay  with  anti-Xpress  or  anti-Flag  antibodies.  (C)  HEK293  cell  lysates  were 
subjected to immunoprecipitation with mouse anti-Dyrk1A or preimmune mouse anti-IgG, followed by immunoblot with anti-ASK1 IgG. The 
cell  lysates  were  also  immunoprecipitated  with  mouse  anti-ASK1  or  preimmune  mouse  anti-IgG,  followed  by  the  immunoblot  with 
anti-Dyrk1A antiserum. The levels of endogenous proteins were measured by immunoblotting with anti-Dyrk1A and anti-ASK1 antibodies, 
as indicated. (D) Where indicated, HEK293 cells were treated with H2O2 (1 mM), TNFα (100 ng/ml), or etoposide (100 μM) for 30 min. 
Cell  lysates  were  subjected  to  immunoprecipitation  with  anti-ASK1,  and  then  immunoblot  assay  was  performed  by  using  anti-Dyrk1A  or 
anti-ASK1  antiserum.
cells  were  transfected  with  Xpress-Dyrk1A  or/and 
Flag-JNK alone or together, cell lysates were immu-
noprecipitated  with  anti-Flag  followed  by  immuno-
blotting  with  anti-Xpress.  As  shown  in  Fig.  3,  the 
anti-Flag-JNK  immunoprecipitates  did  not  include 
Xpress-tagged  Dyrk1A,  suggesting  that  Dyrk1A 
does  not  bind  with  JNK  directly,  whereas  it  is 
related  to  JNK  signaling  pathway.
      Like  as  other  MAP  kinase  family  member,  ERK 
and  p38,  JNK-mediated  signaling  pathway  consists 
of  three  components,  such  as  upstream  MAP3K 
(ASK1), MAP2K (MKK4/7 or SEK1), and JNK/SAPK, 
(JNK1 and JNK2) (Kanamoto et al., 2000). Next we 
examined  whether  Dyrk1A  interacts  with  ASK1. 
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Fig.  5.  Dyrk1A  binds  the  C-terminal  region  of  ASK1.  (A)  The 
diagram of full  length ASK1 and  its deletion mutants. (B) Where 
indicated,  HEK293  cells  were  transfected  for  24  hr  with  Xpress- 
Dyrk1A  or/and  either  HA-tagged  intact  (ASK1  wt)  or  deletion 
ASK1 mutants, such as ASK1-ΔN, ASK1-ΔC, or ASK1-NT. Cell 
lysates  were  subjected  to  immunoprecipitation  with  anti-Xpress, 
and  then  immunoblot  assay  was  performed  by  using  anti-HA  or 
anti-Xpress  IgGs.  Cell  lysates  were  also  immunoblotted  with 
anti-HA  and  anti-Xpress.
or/and Xpress-Dyrk1A alone or together, cell lysates 
were immunoprecipitated with anti-HA and immuno-
blotted with anti-Xpress. As shown in Fig. 4A, when 
the  cells  were  co-transfected  with  Dyrk1A  and 
ASK1, Dyrk1A binds to ASK1. We further investigated 
whether  the  kinase  activity  of  Dyrk1A  is  necessary 
for  its  binding  to  ASK1.  As  shown  in  Fig.  4B, 
HEK293  cells  were  transfected  with  a  plasmid 
encoding  either  Xpress-tagged  wild  type  or  kinase- 
defective Dyrk1A alone or together with Flag-ASK1. 
Co-immunoprecipitation  assay  revealed  that  ASK1 
interacts  with  kinase-deficient  Dyrk1A  as  well  as 
with  wild  type  (Fig.  4B).  These  data  suggest  that 
the  kinase  activity  of  Dyrk1A  appears  not  to  be 
required  for  the  interaction  between  Dyrk1A  and 
ASK1.
    Next we examined whether the mutual interaction 
between  endogenous  Dyrk1A  and  endogenous 
ASK1  still  occurs.  After  HEK293  cell  lysates  were 
immunoprecipitated with mouse anti-Dyrk1A, followed 
by  immunoblotting  with  anti-ASK1  and  anti-Dyrk1A, 
Dyrk1A well interacts with ASK1 endogenously (Fig. 
4C).  Immunoprecipitation  of  the  same  lysates  with 
mouse monoclonal anti-ASK1 antibody with followed 
by  immunoblotting  with  anti-Dyrk1A  in  a  reverse 
order  produced  the  same  binding  band  (Fig.  4C). 
As  a  control,  the  immunoprecipitation  with  mouse 
preimmune  anti-IgG  produced  no  band  with  anti- 
Dyrk1A or anti-ASK1, confirming the validity of assay 
(Fig.  4C).  This  data  confirms  that  the  mutual  inter-
action between ASK1 and Dyrk1A is not an artifact 
arising  from  the  DNA  transfection,  and  still  occurs 
inside  cells.
    To  examine  whether  the  interaction  between 
Dyrk1A and ASK1 is being affected by toxic stimuli, 
including  H2O2,  TNFα,  or  etoposide,  HEK293  cells 
were incubated with each stimuli for 1 hr. When cell 
lysates  were  immunoprecipitated  with  anti-ASK1, 
followed  by  immunoblotting  with  anti-Dyrk1A,  the 
binding of Dyrk1A to ASK1 was significantly increased 
by  the  exposure  with  these  toxic  stimuli  (Fig.  4D). 
While  the  addition  of  TNFα  caused  the  most 
remarkable  increased  binding  of  Dyrk1A  to  ASK1, 
H2O2  and  etoposide  had  less  effect  (Fig.  4D). 
These  results  suggest  that  toxic  stimuli  facilitate 
interaction  between  Dyrk1A  and  ASK1.
Dyrk1A binds to the C-terminal domain of ASK1
    To  identify  the  specific  Dyrk1A-binding  region 
within  ASK1,  several  ASK1  constructs  encoding  its 
deletion  fragments,  such  as  HA-tagged  wild  type 
ASK1,  ASK1-ΔN,  ASK1-ΔC,  and  ASK1-NT,  were 
generated  (Fig.  5A).  After  HEK293  cells  were 
transfected  with  expression  plasmid  encoding  HA- 
tagged  wild  type  ASK1,  ASK1ΔN,  ASK1ΔC,  or 
ASK1-NT  alone  or  together  with  Xpress-Dyrk1A, 
cell  lysates  were  then  subjected  to  immuno-
precipitation  with  anti-HA.  Immunoblotting  of  anti- 
HA-ASK1  complexes  with  anti-Xpress  revealed  that 
Dyrk1A  still  binds  to  ASK1-ΔN  as  well  as  the  full 
length of ASK1 (Fig. 5B). However, Dyrk1A did not 
interact  with  ASK1-ΔC  and  ASK1-NT  (Fig.  5B). 
These results suggest that the C-terminal domain of Functional  Link  between  Dyrk1A  and  ASK1 41
Fig.  6.  Dyrk1A  positively  stimulates  ASK1  and  JNK  activity.  (A) 
Where  indicated,  HEK293  cells  were  mock-transfected  or 
transfected  for  24  hr  with  HA-tagged  kinase-defective  ASK1. 
Then,  the  cells  were  left  un-stimulated  or  treated  with  TNFα
(100 ng/ml), H2O2 (1 mM), or etoposide (100 μM) for 1 hr. After 
cell  lysates  were  immunoprecipitated  with  anti-Dyrk1A,  the  levels 
of  Dyrk1A  and  active  Dyrk1A  in  the  immunocomplexes  were 
analyzed by immunoblot with anti-Dyrk1A and anti-phosphotyrosine 
antiserum.  Toxin-induced  JNK  activation  and  the  proper  expre-
ssion  of  HA-ASK1  were  examined  by  immunoblotting  of  cell 
lysates  with  anti-HA,  anti-phosphoJNK,  or  anti-JNK  antibodies. 
(B) After HEK293 cells were mock-transfected or transfected with 
Xpress-tagged  kinase-defective  Dyrk1A  for  24  h,  the  cells  were 
left  untreated  or  with  TNFα  ( 1 0 0  n g / m l ) ,  H 2O2 ( 1  m M ) ,  o r  
etoposide (100 μM) for 1 hr, as indicated. The activation of ASK1 
was  examined  by  immunoblot  assay  using  anti-phospho  ASK1 
(Thr-845).  The  levels  of  HA-ASK1,  JNK,  and  active  JNK  in  cell 
lysates  were  also  immunoblotted  with  anti-Xpress,  anti-JNK,  or 
anti-phosphoJNK  antibodies,  respectively.
ASK1  spanning  937∼1145
th  amino  acid  is  critical 
for  the  interaction  with  Dyrk1A.
Dyrk1A lies on the upstream of ASK1 in toxin- 
induced  JNK  signal  transduction
    Based on the finding that Dyrk1A is linked to JNK 
signaling pathway and interacts with ASK1, we next 
examined  how  Dyrk1A  is  linked  to  ASK1  and/or 
JNK signaling cascades. To firstly determine whether 
the  activation  of  Dyrk1A  is  mediated  by  ASK1, 
HEK293  cells  were  mock-transfected  or  transfected 
with  Flag-tagged  kinase  defective  ASK1  for  24  hr. 
After  treatment  with  TNFα,  cell  lysates  were  then 
immunoprecipitated  with  anti-Dyrk1A,  followed  by 
immunoblotting with anti-phosphotyrosine. As shown 
in Fig. 6A, the exposure of TNFα caused the acti-
vation of Dyrk1A as well as JNK, and the presence 
of  kinase-defective  ASK1  resulted  in  the  significant 
reduction  of  JNK  activity,  suggesting  that  ASK1  is 
present upstream of JNK. Unlike to JNK, the levels 
of  phospho-Dyrk1A  levels  were  not  changed  re-
markably by kinase-inactive ASK1, compared to the 
cells  in  the  absence  of  ASK1  mutants  (Fig.  6A). 
When the same experiments were performed under 
the  condition  of  H2O2-  and  etoposide-induced  cell 
death,  the  similar  activation  pattern  of  JNK  and 
Dyrk1A  was  observed  in  HEK293  cells,  whereas 
these  two  stimuli  caused  much  less  activation  of 
Dyrk1A  than  TNFα (Fig.  6A).  However,  the  pre-
sence  of  kinase-defective  ASK1  did  not  affect  the 
activation  of  Dyrk1A  induced  by  H2O2  and  etopo-
side (Fig. 6A). Taken together, these results suggest 
that  ASK1  does  not  affect  Dyrk1A  activity.
    We  next  examined  whether  Dyrk1A  acts  as  an 
upstream  regulator  of  ASK1-JNK  signaling.  After 
HEK293  cells  were  co-transfected  with  HA-ASK1 
alone  or  together  with  kinase-defective  Xpress- 
Dyrk1A-K188R,  the  activation  pattern  of  ASK1  and 
JNK under the condition of toxin-induced cell death 
was  determined  by  immunoblot  assay  with  anti- 
phospho  ASK1  and  anti-phospho  JNK.  As  shown 
Fig.  6B,  when  the  cells  were  co-transfected  with 
ASK1  plus  kinase-defective  Dyrk1A,  the  activation 
of ASK1 and JNK was significantly inhibited by TNF
α,  H2O2,  and  etoposide,  compared  with  the  cells 
transfected  with  ASK1  alone.  These  data  indicated 
that  Dyrk1A  as  a  upstream  regulator  positively 
modulates ASK1-JNK signaling during toxin-induced 
cell  death.
    To examine Dyrk1A directly phosphorylates ASK1, 
in  vitro  kinase  assay  was  performed.  After  trans-
fected  with  a  plasmid  encoding  Xpress-Dyrk1A  for 
24  h,  HEK293  cells  were  stimulated  with  eto-
poside.  Then,  cell  lysates  were  immunoprecipitated 
with  anti-Xpress  antiserum,  followed  by  in  vitro 
kinase  assay  by  using  bacterial  recombinant 
ASK1
750-1013  or ASK1
1014-1374  fragment fused to GST 
as  a  substrate.  As  shown  in  Fig.  7,  both  of  these 
two  ASK1  fragments  were  well  phosphorylated  by 
Dyrk1A.  These  results  suggest  that  Dyrk1A  directly 
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Fig.  7.  Dyrk1A  directly  phosphorylates  the  C-terminal  domain  of 
ASK1.  Where  indicated,  HEK293  cells  were  mock-transfected  or 
transfected  with  Xpress-Dyrk1A  for  24  h.  Then,  the  cell  lysates 
were  immunoprecipitated  with  anti-Xpress,  and  the  immunocom-
plexes  was  subjected  to  in  vitro  kinase  assay  with  GST-tagged 
recombinant ASK1 fragments, such as GST-ASK1
750-1013 or GST- 
ASK1
1014-1375  a s  a  s u b s t r a t e .
DISCUSSION
    Dyrk1A activity is involved in cell proliferation and 
differentiation  (Dierssen  and  de  Lagran,  2006).  For 
example,  while  Ras-dependent  signaling  is  required 
for promoting or maintaining neuronal differentiation, 
Dyrk1A  modulates  ERK  activation  by  interacting 
with  Ras,  B-Raf,  and  MEK1  and  by  facilitating  the 
formation of a Ras/B-Raf/MEK1 multi-protein complex 
(Kelly and Rahmani, 2005). Recently, many studies 
implicated  a  potential  role  of  Dyrk1A  during  cell 
death.  For  example,  Dyrk1A  caused  the  formation 
of  abnormal  protein  aggregates  through  the  phos-
phorylation  of  α-synuclein,  APP,  and  tau  (Kim  et 
al.,  2006;  Park  et  al.,  2007;  Ryoo  et  al.,  2008). 
Furthermore, these cells show a marked increase of 
apoptotic  cell  death  (Park  et  al.,  2007),  indicating 
that  the  overexpression  of  Dyrk1A  induces  cell 
death.  Moreover,  Dyrk1A  seems  to  participate  in 
the pathogenesis of Huntington disease by modula-
ting  the  interaction  of  toxic  huntingtin  and  Hip-1  in 
hiipocampal  neuronal  cells  (Kang  et  al.,  2005). 
However,  the  functional  role  of  Dyrk1A  during  cell 
death  and  its  signal  transduction  pathway  have  not 
been  elucidated  yet.  Presently,  we  demonstrated 
that  the  activation  of  Dyrk1A  occurs  during  toxin- 
induced  cell  death,  including  TNFα,  hydrogen 
peroxide, and  etoposide.  In addition,  while  the  acti-
vation  of  Dyrk1A  is  linked  to  and  positively  stimu-
lates  JNK-signaling,  Dyrk1A  did  not  directly  bind  to 
JNK.
    Pro-apoptotic  ASK1  mediates  the  induction  of 
apoptosis  under  the  stimulation  of  diverse  stress 
through  the  activation  of  JNK  signaling  pathway. 
This  hypothesis  was  confirmed  by  the  current  find-
ing.  We  demonstrated  that  Dyrk1A  physically 
interacts  with  ASK1  and  enhances  ASK1  and  acts 
as  a  positive  regulator  of  ASK1.  Moreover,  Dyrk1A 
appears  to  directly  phosphorylate  the  C-terminal 
domain  of  ASK1.  Similar  to  Dyrk1A,  several  pro-
teins  were  reported  to  positively  regulate  ASK1 
activity.  For  example,  TRAF  family  and  Gemin5 
promoted the homo-oligomerization of ASK1 (Nishitoh 
et al., 1998; Kim et al., 2007), and CaMKII induces 
the  phosphorylation  of  ASK1  in  Ca
2＋-influx  condi-
tion (Takeda et al., 2004). Further study is required 
how  Dyrk1A  positively  regulates  ASK1.
    The  Dyrk  family  consists  of  five  mammalian 
members  (Dyrk1A,  Dyrk1B,  Dyrk2,  Dyrk3,  and 
Dyrk4).  Among  these  family  members,  Dyrk1A  is 
the  only  member  located  on  chromosome  21. 
Dyrk1A  contains  multiple  domains,  including  a 
nuclear  localization  signal  at  the  N-terminus,  a 
kinase  domain,  a  PEST  domain  for  protein  degra-
dation, a 13-consecutive-histidine repeat, and an S/T 
rich  region.  Even  though  Dyrk1A  has  a  nuclear 
localization signal and 13 histidine repeat for nuclear 
speckle targeting, Dyrk1A has been detected in the 
soma and dendrites of  neurons.  Therefore, it is not 
surprising  that  Dyrk1A  substrates  comprise  both 
nuclear  and  cytosolic  proteins,  including  transcrip-
tional  factors  (CREB,  NFAT,  STAT3,  FKHR,  Gli1), 
splicing  factors  (cyclin  L2,  SF2,  SF3),  a  translation 
factor  (eIF2Bε),  and  synaptic  proteins  (dynamin  I, 
amphiphysin  I,  synaptojanin  I).  Expanding  the 
substrate  diversity  and  pleiotropic  roles  for  Dyrk1A, 
the  current  finding  demonstrates  that  Dyrk1A  inter-
acts with and phosphorylates other cytosolic protein 
kinase,  ASK1.
    Although  Dyrk1A  is  linked  to  JNK  signal  trans-
duction  pathway  during  cell  death,  the  direct  effect 
of Dyrk1A on cell viability or cell death/ survival was 
not  assessed  yet.  The  current  finding  that  Dyrk1A 
enhances the activities of ASK1 and JNK1, it could 
act  as  a  pro-apoptotic  player.  This  speculation  was 
further  supported  by  the  previous  reports.  For 
example, the activation of Dyrk1A has been reported 
in several neurodegenerative diseases, such as DS 
and  AD.  For  example,  Ts65Dn  mouse,  a  well- Functional  Link  between  Dyrk1A  and  ASK1 43
known  mouse  model  of  DS  with  abnormal  1.5-fold 
accumulation of Dyrk1A, exhibits hippocampal hypo-
cellularity  in  early  development  and  adult  (Lorenzi 
and  Reeves,  2006),  and  increased  mitochondrial 
superoxide  level  (Schuchmann  and  Heinemann, 
2000).  Besides,  the  susceptibility  of  cell  death  has 
been  increased  in  various  types  of  cells  from  DS 
patients  (Busciglio  and  Yankner,  1995;  Roat  et  al., 
2007). Furthermore, the cells overexpressing Dyrk1A 
exhibited abnormal processing of several AD-related 
pathogenic  proteins  (Park  et  al.,  2007).  Like  to 
Dyrk1A,  ASK1  activity  also  contributes  to  the  cell 
death  in  the  neurodegenerative  diseases,  including 
AD  and  HD.  The  accumulation  of  intracellular 
aggregates  induced  cellular  stress,  which  subse-
quently  leads  to  neuronal  cell  death  in  an  ASK1- 
dependent  manner  in  HD  (Nishitoh  et  al.,  2002). 
ROS-induced  activation  of  ASK1  is  also  a  key 
mechanism  for  β-amyloid-induced  neurotoxicity  in 
AD (Hashimoto et al., 2003; Kadowaki et al., 2005). 
Based  on  these  previous  reports,  it  would  be 
interesting  to  examine  whether  and  how  Dyrk1A 
leads  to cell  death  through  ASK1-JNK signal  trans-
duction.
    In conclusion, the current study demonstrated that 
Dyrk1A  positively  regulates  ASK1-JNK  activation 
during  toxin-induced  cell  death.
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